Host: |
Goat |
Applications: |
Pep-ELISA/WB/IHC/FC |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-MS2/ADAM8/CD156 (C-Term) is suitable for use in ELISA, Western Blot, Immunohistochemistry and Flow Cytometry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:16000.WB: Approx. 90kDa band observed in lysates of cell line Caco-2, approx. 80kDa in Human Duodenum lysates and approx. 85kDa in preliminary testing of MCF7 cell lysate (calculated MW of 88.8k |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
ADAM8 |
Gene ID: |
101 |
Uniprot ID: |
ADAM8_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_001100.3; NP_001157962.1 |
Specificity: |
This antibody is expected to recognise isoform 1 and 3 (NP_001100.3; NP_001157962.1). |
Immunogen Sequence: |
QRKQGAGAPTAP |
Function | Possible involvement in extravasation of leukocytes. |
Protein Name | Disintegrin And Metalloproteinase Domain-Containing Protein 8Adam 8Cell Surface Antigen Ms2Cd Antigen Cd156a |
Database Links | Reactome: R-HSA-1474228Reactome: R-HSA-6798695 |
Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Disintegrin And Metalloproteinase Domain-Containing Protein 8 antibodyAnti-Adam 8 antibodyAnti-Cell Surface Antigen Ms2 antibodyAnti-Cd Antigen Cd156a antibodyAnti-ADAM8 antibodyAnti-MS2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance